Keren Levanon, MD, PhD

KerenLevanon
Institution: Dana-Farber Cancer Institute
Category: Investigating how ovarian cancer begins and progresses

Keren Levanon, MD, PhD
Dana-Farber Cancer Institute

The Fallopian Tube as field of origin of ovarian serous carcinoma

Research on ovarian carcinogenesis has traditionally focused on the ovarian surface epithelium as the fields of origin. More recently, the secretory cell of the fallopian tube has emerged as an alternate cell-of-origin for ovarian and pelvic serous carcinomas, the most aggressive subtype of the disease. Under the direction of mentors Dr. Ron Drapkin and Dr. Christopher Crum, the ultimate goal of this project is to elucidate the fundamental processes that lead to ovarian serous tumorigenesis.